Here are relevant reports on : human-resources-hiring-market
-
Monoclonal Antibody Therapeutics Market / mABs Therapeutics Market Size by Production Method (In-Vitro, In-Vivo), Sources (Human, Chimeric), Route of Administration (Intravenous, Subcutaneous), Therapy (Inflammatory & Autoimmune, Oncology, Hematology) - Global Forecast to 2029
The global monoclonal antibody therapeutics market, valued at US$222.6 billion in 2023, stood at US$252.6 billion in 2024 and is projected to advance at a resilient CAGR of 14.5% from 2024 to 2029, culminating in a forecasted valuation of US$497.5 billion by the end of the period. Driving factors of the market, including clinical trials, encompass increasing prevalence of complex diseases, advancements in biotechnology facilitating targeted treatments, regulatory support expediting approval processes, and robust investments in research and development.
- Published: March 2024
- Price: $ 4950
- TOC Available:
-
Wealth Management Platform Market by Advisory Model (Human Advisory, Robo Advisory, and Hybrid), Business Function (Reporting, Portfolio, Accounting, and Trading Management), Deployment Model, End-User Industry, and Region - Global Forecast to 2022
The global wealth management platform market size is expected to grow from USD 1.70 Billion in 2017 to USD 3.20 Billion by 2022, at a Compound Annual Growth Rate (CAGR) of 13.4% during the forecast period. The wealth management platform ecosystem comprises vendors, such as SS&C Technologies, Inc. (US), Fiserv, Inc. (US), Fidelity National Information Services (US), Profile Software (UK), Broadridge Financial Solutions, Inc. (US), InvestEdge, Inc. (US), Temenos Group AG (Switzerland), Finantix S.p.A. (Italy), SEI Investments Company (US), Comarch SA (Poland), Objectway S.p.A. (Italy), and Dorsum Ltd. (Hungary). The other stakeholders of the wealth management platform market include managed service providers, third-party providers, and technology providers.
- Published: March 2018
- Price: $ 4950
- TOC Available:
-
Primary Cells Market by Type (Hematopoietic, Dermatocytes, Hepatocytes, Gastrointestinal, Lung, Renal, Heart, Musculoskeletal), Origin (Human Primary Cells, Animal Primary Cells), End User (Pharma Biotech, CROs, Academia), Region - Global Forecast to 2028
The global primary cells market, valued at US$1.5 billion in 2022, stood at US$1.7 billion in 2023 and is projected to advance at a resilient CAGR of 10.5% from 2023 to 2028, culminating in a forecasted valuation of US$2.8 billion by the end of the period. The growth of this market can be attributed to factors such as the is the growing advantages of primary human cells over cell lines, rising growth in pharmaceutical & biotechnology industries, increasing demand for monoclonal antibodies, Government investments for cell-based research, and increasing cancer research.
- Published: July 2023
- Price: $ 4950
- TOC Available:
-
Human Identification Market by Product [Consumables (Kits & Reagents), Instruments, Software], Technology (PCR, Capillary Electrophoresis, NGS, Microarray, Rapid DNA Analysis), Application (Forensics, Paternity Testing), End User - Global Forecast to 2031
The global human identification market, valued at USD 0.89 billion in 2025, stood at USD 1.01 billion in 2026 and is projected to advance at a resilient CAGR of 10.9% from 2026 to 2031, culminating in a forecasted valuation of USD 1.69 billion by the end of the period. The key players include Thermo Fisher Scientific Inc. (US), QIAGEN N.V. (Netherlands), Promega Corporation (US), Hamilton Company (US), FUJIFILM Wako Pure Chemical Corporation (Japan), ANDE (US), AutoGen Inc. (US), InnoGenomics Technologies, LLC (US), Oxford Nanopore Technologies Plc (UK), Bode Cellmark Forensics Inc. (US), Carolina Biological Supply (US), Genetek Biopharma GmbH (Germany), STRmix Limited (New Zealand), Ningbo HEALTH Gene Technologies Co., Ltd. (China), and SoftGenetics (US).
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Smart Airports (Airport Real Time Collaboration, Seamless Travel, Human Recognition Detection) Market, By Products, Technology, Application & Geography - 2019
- Published: October 2026
- Price: $ 4950
- TOC Available:
-
Serious Game Market by Vertical (Education, Corporate, Healthcare, Retail, Media and Advertising), Application (Training, Sales, Human Resource, Marketing), Platform, End-User (Enterprise, Consumer) - Global Forecast to 2035
The Serious Game Market is experiencing rapid growth as organizations increasingly adopt game-based learning and simulation technologies for education, corporate training, healthcare, defense, manufacturing, and workforce development. The market is estimated at USD 18.0 billion in 2025 and is projected to reach approximately USD 52.0 billion by 2035, registering a CAGR of 11.2% during the forecast period. Key growth drivers include digital learning transformation, workforce upskilling, immersive training requirements, and increasing demand for cost-effective simulation-based learning. The integration of Artificial Intelligence (AI), IoT, cloud computing, augmented reality (AR), virtual reality (VR), and automation is further enhancing serious games through adaptive learning, intelligent virtual instructors, real-time analytics, automated content generation, and personalized training experiences.
- Published: October 2026
- Price: $ 4950
- TOC Available:
-
Defense Electronics Obsolescence Market by System (Communication System; Navigation System; Human Machine Interface; Flight Control System; Targeting System; Electronic Warfare System; and Sensors), Type & Region - Global Forecast to 2028
The defense electronics obsolescence market is expected to grow from USD 2.5 billion in 2023 to USD 3.7 billion by 2028, at a compound annual growth rate (CAGR) of 8.2% during the forecast period.The key players Raytheon Technologies Corporation (US), BAE Systems (UK), L3Harris Technologies, Inc. (US), Thales (US) and Elbit Systems Ltd. (Israel).
- Published: March 2024
- Price: $ 4950
- TOC Available:
-
Probiotics Market Report by Product Type (Functional Food & Beverages (FnB), Dietary Supplements, and Feed), Ingredient (Bacteria and Yeast), End User (Human and Animal), Distribution Channel, and Region - Global Forecast to 2030
The global probiotics market is estimated to be valued at USD 76.59 billion in 2025 and is projected to reach USD 114.95 billion by 2030, growing at a CAGR of 8.5% from 2025 to 2030. Key players in this market include Probi (Sweden), Nestlé (Switzerland), ADM (US), Danone (France), International Flavors & Fragrances Inc. (US), Yakult Honsha Co., Ltd. (Japan), BioGaia (Sweden), MORINAGA MILK INDUSTRY CO., LTD. (Japan), Meiji Holdings Co., Ltd. (Japan), Lifeway Foods, Inc. (US), Adisseo (France), Winclove Probiotics (US), AB-Biotics, S.A. (Belgium), Apsen Farmacêutica (Brazil), and Lallemand (Canada).
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
BPaaS Market by Business Process (Human Resource Management, Customer Service & Support, Accounting & Finance, Sales & Marketing, Procurement, SCM, and Operations), Deployment Model (Public, Private, Hyrbid Cloud) - Global Industry Forecast to 2028
The BPaaS market size is USD 92.2 billion by 2028 at a Compound Annual Growth Rate (CAGR) of 8.0% during the forecast period. Some of the key players operating in the BPaaS market are – Accenture (Ireland), Capgemini (France), Cognizant (US), IBM (US), HCL (India), TCS (India), Fujitsu (Japan), Genpact(US), Wipro (India), Tech Mahindra (India), EXL (US), DXC Technology (US), Conduent (US), Infosys BPM (India), Bizagi (US).
- Published: February 2024
- Price: $ 4950
- TOC Available:
-
Nutraceutical Ingredients Market by Ingredient Type (Functional Proteins, Amino Acids, Probiotics, Others), Application (Human Nutrition, Animal Nutrition), Source (Plant-Based, Animal-Based, Others), Function, and Region - Global Forecast to 2031
The global nutraceutical ingredients market is projected to grow from USD 108.33 billion in 2026 to reach USD 161.53 billion by 2031, at a CAGR of 7.3%. The key players include Cargill, Incorporated (US), ADM (US), International Flavors & Fragrances Inc. (US), BASF (Germany), Glanbia PLC (Ireland), Arla Foods amba (Denmark), Ingredion (US), Tate & Lyle (UK), Roquette Frères (France), Novonesis (Denmark), and Associated British Foods PLC (UK), among others.
- Published: September 2026
- Price: $ 4950
- TOC Available:
Records 41 to 50 of 50
